Novascan Inc.

Chicago, IL · Medtech · Private

AI-enhanced real-time surgical margin assessment system for cancer detection

Claim this profile

Follows are private to you and power your alerts

Updated · novascaninc.com

Sector
Medtech
Headquarters
Chicago, IL
Latest Form D
$671K, May 2026
Total capital
$821K
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$821K
5 Form D · last May 2026
5 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
3
22 pending · first 2020
Rank in peer group#370 of 1112

Capital timeline

20172019202120232025FEDERAL ↑EQUITY ↓Cumulative $11.8M1st Form D$50K2nd Form D$100K4th Form D$3M5th Form D$671K
20172019202120232025FEDERAL ↑EQUITY ↓Cumulative $11.8M4th Form D$3M

Latest events

  • Private capital raisedForm D · SEC · 5th filing$671K
  • Offering registeredForm D · SEC · 4th filing$3M
  • Offering registeredForm D · SEC · 3rd filing$8M
  • Private capital raisedForm D · SEC · 2nd filing$100K
  • Private capital raisedForm D · SEC · 1st filing$50K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#370 · top 33%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Amit MehtaExecutive Officer, DirectorNamed in SEC Form D filings
  • Charles LinkDirectorNamed in SEC Form D filings
  • Craig DavisExecutive Officer, Director, PromoterNamed in SEC Form D filings
  • C. Richard PiazzaDirectorNamed in SEC Form D filings
  • C. Richard PlazzaDirectorNamed in SEC Form D filings
  • Joel WeinsteinDirectorNamed in SEC Form D filings
Show all 10 people
  • Robert ZierselDirectorNamed in SEC Form D filings
  • Tsuri BernsteinExecutive Officer, DirectorNamed in SEC Form D filings
  • William GregoryExecutive Officer, DirectorNamed in SEC Form D filings
  • William WangerinDirectorNamed in SEC Form D filings

What it has protected

USPTO · 3 granted of 25
  • GrantedImpedance-calibrated Diagnostic Medical DevicesUSPTOUS 12,678,066
  • PendingImpedance Measurement Using Bipolar Configurations Of ElectrodesUSPTOApplication 18949077
  • PendingTechniques For Assessing Cancerous Tissue During Surgical BiopsiesUSPTOApplication 18485265
Show all 25 patent records
  • Impedance-calibrated Diagnostic Medical DevicesJul 14, 2026 · US 12,678,066Granted
  • Impedance Measurement Using Bipolar Configurations Of ElectrodesMay 21, 2026 · Application 18949077Pending
  • Techniques For Assessing Cancerous Tissue During Surgical BiopsiesApr 18, 2024 · Application 18485265Pending
  • Tissue Type Detecting Medical DevicesDec 1, 2022 · Application 17819563Pending
  • Prostate Cancer Detecting Medical DevicesAug 11, 2022 · Application 17732390Pending
  • Techniques For Determining Tissue TypesJul 28, 2022 · Application 17695745Pending
  • Techniques For Controlling Medical Device ToolsJul 28, 2022 · Application 17412973Pending
  • Medical Devices Configured With Needle ElectrodesJul 28, 2022 · Application 17695748Pending
  • Techniques For Detecting Cancerous Cells In Excised Tissue Samples Using Impedance DetectionSep 1, 2020 · US 10,758,151Granted
  • Techniques For Predicting Recurrence Of Cancerous Cells Using Impedance DetectionAug 11, 2020 · US 10,736,536Granted
  • Compensation for Length of Tethers in CRF MeasurementsApplication 63142247Pending
  • EndoScope Bronchoscope Instrument for Detecting CRF Measurements in TissueApplication 63142260Pending
  • Techniques For Predicting Recurrence Of Cancerous Cells Using Impedance DetectionApplication PCTUS2019020089Pending
  • Techniques For Predicting Recurrence Of Cancerous Cells Using Impedance DetectionApplication 62636798Pending
  • Techniques For Detecting Cancerous Cells In Excised Tissue Samples Using Impedance DetectionApplication PCTUS2018014662Pending
  • Impedance-calibrated Diagnostic Medical DevicesApplication PCTUS2022014157Pending
  • Techniques For Assessing Cancerous Tissue During Surgical BiopsiesApplication PCTUS2023076742Pending
  • Tissue Type Detecting Medical DevicesApplication PCTUS2023071871Pending
  • Medical Devices Configured With Needle ElectrodesApplication PCTUS2023064363Pending
  • Techniques For Determining Tissue TypesApplication PCTUS2023064362Pending
  • Techniques For Assessing Cancerous Tissue During Surgical BiopsiesApplication 63379613Pending
  • Impedance Measurement Using Bipolar Configurations Of ElectrodesApplication PCTUS2025054832Pending
  • Techniques For Controlling Medical Device ToolsApplication PCTUS2022014159Pending
  • Targeted Drug and Energy Delivery with CRF MeasurementsApplication 63142242Pending
  • Needle Electrodes for CRF MeasurementsApplication 63142254Pending
  • eBeam Film LLCSimilar federal contract value in Medtech · null in contracts
  • SYMBIOS TECHNOLOGIES INC.Similar federal contract value in Medtech · null in contracts
  • EYE AMERICA LLCSimilar federal contract value in Medtech · null in contracts
  • Circulate Inc.Similar federal contract value in Medtech · null in contracts
  • Linshom Medical Inc.Similar federal contract value in Medtech · null in contracts
  • CLEARCAM INCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .